2187 ⎘
Genetically modified animals; Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Antibodies that specifically bind to DRG11-responsive (dragon) proteins
#602Antibodies that specifically bind to DRG11-responsive (dragon) proteins
#603IncRNA-knockout mice
#604Genetically modified major histocompatibility complex mice
#605Animal models and therapeutic molecules
#606Isolated cell comprising a nucleic acid encoding antibody inhibitors of gdf-8 and uses thereof
#607Isolated cells from humanized FcγR mice
#608Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
#609RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
#610Transgenic transchromosomal rodents for making human antibodies
#611Production of heavy chain only antibodies in transgenic mammals
#612SWINE GENETICALLY MODIFIED WITH SPECIFICITY FOR LDL-R KNOCKOUT
#613Vascular endothelial growth factor 2
#614MCPIP as wound therapy
#615Antibodies, variable domains and chains tailored for human use
#616Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
#617Antibody producing non-human mammals
#618TRANSGENIC BIRDS THAT PRODUCE CHIMERIC HUMAN IMMUNOGLOBULINS
#619Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors
#620Antibody producing non-human mammals
#621Protein having nuclease activity, fusion proteins and uses thereof
#622Mice that make heavy chain antibodies
#623Antibodies that bind integrin alpha-V beta-8
#624Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#625Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders
#626Chimeric non-human animal carrying human hepatocyte
#627Animal models of duchenne muscular dystrophy
#628Method and apparatus for data transmission using multiple transmit antennas
#629Boosting human dendritic cell development, homeostasis and function in xenografted immunodeficient mice
#630Low affinity FCGR deficient mice
#631Humanized Fc gamma R mice
#632Animal models and therapeutic molecules
#633Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
#634Mitochondrial targeting and therapeutic use thereof
#635Genetically modified non-human animals and methods of use thereof
#636Transgenic non-human animal model of neurodegenerative disease
#637Animal models and therapeutic molecules
#638Porcine reproductive and respiratory syndrome virus resistant animals
#639Mouse for predicting a behavior of drugs in humans
#640Genetically modified mice and engraftment
#641Non-human animals expressing pH-sensitive immunoglobulin sequences
#642Transgenic chicken comprising an inactivated immunoglobulin gene
#643Efficient protein expression in vivo using modified RNA (MOD-RNA)
#644Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
#645Antibodies that specifically bind SOST and WISE peptides
#646Epo knockout GFP anemic mouse
#647Elimination of N-glycolylneuraminic acid from animal products for human use
#648Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
#649Methods for treating metabolic syndrome with Cthrc1 polypeptide
#650Transgenic mouse having a genome comprising a homozygous disruption of the endogenous MFN2 gene expression in the dopaminergic neurons
#651Methods for treating disorders that involve immunoglobulin A
#652Animal models and therapeutic molecules
#653Micro-RNA family that modulates fibrosis and uses thereof
#654Micro-RNA family that modulates fibrosis and uses thereof
#655Non-human animals expressing pH-sensitive immunoglobulin sequences
#656Mice that produce antigen-binding proteins with pH-dependent binding characteristics
#657Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
#658Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#659Substances and compositions for enhancing DNA repair and methods of use
#660Hairless NOD scid mouse
#661Animal models of atherosclerosis
#662RNA sequence-specific mediators of RNA interference
#663Micro-RNA family that modulates fibrosis and uses thereof
#664Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof
#665In vivo gene silencing by chemically modified and stable siRNA
#666Antibody producing non-human mammals
#667Compositions and methods for increasing bone mineralization
#668Role of PI3K P110 Delta Signaling in Retroviral Infection and Replication
#669Genetically modified major histocompatibility complex mice
#670Methods for inhibiting hematopoiesis with a hedgehog antagonist
#671hnRNP A1 KNOCKOUT ANIMAL MODEL AND USE THEREOF
#672Gene for Identifying Individuals with Familial Dysautonomia
#673In vivo gene regulation by the combination of knock-in-tetO sequence into the genome and tetracycline-controlled trans-suppressor (tTS) protein
#674Screening of drug for attention deficit hyperactive disorder by using GIT1 knock-out mice as a novel ADHD mouse model
#675CD4 T-cells and CD8zeta cells involved in mammalian host response to epithelial cell infections and uses thereof
#676Genetically altered animal specimen and related methods
#677Mouse λ light chain locus
#678Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#679Transgenic mouse homozygous for chimeric IgH locus
#680Methods and means for increasing resistance to cell damage
#681Elimination of N-glycolylneuraminic acid from animal products for human use
#682Treatment of Pompe's Disease
#683Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration
#684Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs
#685LENTIVIRAL VECTORS THAT PROVIDE IMPROVED EXPRESSION AND REDUCED VARIEGATION AFTER TRANSGENESIS
#686Genetically modified mice and engraftment
#687Antibody to peptide
#688Genetically modified mice and engraftment
#689WISE/SOST NUCLEIC ACID SEQUENCES AND AMINO ACID SEQUENCES
#690Methods and compositions to modulate antiviral and immune activity responses
#691Pathogen restriction factors
#692Lysyl oxidase-like 1 (LOXL1) and elastogenesis
#693SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
#694Tumor suppressor designated TS10Q23.3
#695METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS
#696Compositions and methods for preparing recombinant MG53 and methods for optimizing same
#697METHODS FOR TREATING DISEASES
#698Histone deacetylases, and uses related thereto
#699METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION
#700MOUSE MODEL FOR AVM
#701Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase
#702Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
#703Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#704STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#705NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
#706GLYCINE N-METHYLTRANSFERASE (GNMT) ANIMAL MODEL AND USE THEREOF
#707METHODS AND COMPOSITIONS RELATING TO ZPA POLYPEPTIDES
#708Low affinity FcγR deficient mice
#709Porcine Animals Lacking Any Expression of Functional Alpha 1,3 Galactosyltransferase
#710Inducible small RNA expression constructs for targeted gene silencing
#711ACE2 activation for treatment of heart, lung and kidney disease and hypertension
#712JNK3 MODULATORS AND METHODS OF USE
#713Non-human mammalian animal model for type 2 diabetes
#714MO-1 conditional knock-out non-human animal and uses thereof
#715GENETICALLY MODIFIED ANIMALS AND METHODS FOR MAKING THE SAME
#716Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
#717Composition comprising rna derived from lactic acid bacterium as effective component
#718Methods and materials for producing transgenic artiodactyls
#719NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS
#720VASCULAR ENDOTHELIAL GROWTH FACTOR 2
#721Novel gene disruptions, compositions and methods relating thereto
#722Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#723Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity
#724DRG11-responsive (dragon) polypeptides
#725DRG11-responsive (DRAGON) gene family
#726ANIMAL MODELS AND THERAPEUTIC MOLECULES
#727COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USE
#728UBIQUITIN INTERACTING MOTIF PEPTIDES AS CANCER THERAPEUTICS
#729Compositions and Methods for Preventing or Treating Influenza Virus Infection
#730PNMT as a novel marker for progenitor cells
#731DOUBLE MUTANT MOUSE AND CELL LINES
#732TRANSGENIC MOUSE MODEL FOR DEVELOPING ENZYME REPLACEMENT THERAPY FOR IDURONATE-2-SULFATASE DEFICIENCY SYNDROME
#733Transgenic pig model of cystic fibrosis
#734Diagnosis of depression
#735DRG11-responsive (DRAGON) gene family
#736Profiling fragments of elastic fibers and microfibrils as biomarkers for disease
#737Mouse model for diagnosis of T cell acute lymphoblastic leukemia and for screening of therapeutic agents, and methods of use therefor
#738Novel PRO1199 gene disruptions, and methods relating thereto
#739ANIMAL MODELS AND THERAPEUTIC MOLECULES
#740Method of predicting a behavior of one or more drugs
#741FUNCTIONAL DISRUPTION OF AN IMMUNOGLOBULIN GENE IN AN AVIAN EMBRYONIC STEM CELL
#742Genetically Modified Rat Models for Pain
#743INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#744Method and apparatus for data transmission using multiple transmit antennas
#745Method for preventing and treating cardiovascular diseases with BRCA1
#746NON HUMAN ANIMAL MODELS FOR INCREASED RETINAL VASCULAR PERMEABILITY
#747Method of Genetically Altering and Producing Allergy Free Cats
#748DHX36 / RHAU KNOCKOUT MICE AS EXPERIMENTAL MODELS OF MUSCULAR DYSTROPHY
#749DNA FRAGMENT AND PHARMACEUTICAL COMPOSITION
#750RNA sequence-specific mediators of RNA interference
#751HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENOMICE
#752CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
#753Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
#754TRUNCATED ACTIVIN TYPE II RECEPTOR AND METHODS OF USE
#755BOOSTING HUMAN DENDRITIC CELL DEVELOPMENT, HOMEOSTASIS AND FUNCTION IN XENOGRAFTED IMMUNODEFICIENT MICE
#756Molecular Interactions in Hematopoietic Cells
#757Rat having a disrupted immunoglobulin gene
#758Immunocompromised Ungulates
#759NPC1L1 (NPC3) AND METHODS OF USE THEREOF
#760Chromosome 3p21.3 genes are tumor suppressors
#761Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
#762Immunoadjuvant composition and use thereof
#763Mouse model for pompe disease and methods of use thereof
#764Methods of diagnosing hypophosphatemic disorders
#765Use of Guanylyl Cyclase C Agonists to Suppress Appetite
#766Caveolin 1-reporter protein knock-in mouse
#767Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
#768Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
#769METHOD OF EXPANDING HUMAN HEPATOCYTES IN VIVO
#770The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
#771METHOD FOR OBSERVING GAD67-POSITIVE CELL IN TRANSGENIC ANIMAL
#772NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
#773RNA sequence-specific mediators of RNA interference
#774INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#775Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
#776GENOME EDITING OF CYTOCHROME P450 IN ANIMALS
#777Antibody to SOST peptides
#778Compositions and methods for treating kidney disease
#779RNA sequence-specific mediators of RNA interference
#780Wise/Sost nucleic acid sequences and amino acid sequences
#781Methods of identifying agents that modulate phenotypes related to disruptions, of a gene encoding PRO235 polypeptide
#782Antibodies to JTT-1 protein and cells secreting such antibodies
#783Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function
#784Histone deacetylases, and uses related thereto
#785Histone deacetylases, and uses related thereto
#786Production of fertile XY animals from XY ES cells
#787RNA interference mediating small RNA molecules
#788CALCIUM SENSOR STIM1 AND THE PLATELET SOC CHANNEL ORAI1 (CRACM1) ARE ESSENTIAL FOR PATHOLOGICAL THROMBUS FORMATION
#789MODIFIED ORGANS AND CELLS FOR XENOTRANSPLANTATION
#790Human CTLA-4 antibodies and their uses
#791RNA sequence-specific mediators of RNA interference
#792Use of VEGF and homologues to treat neuron disorders
#793INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#794MG53 COMPOSITIONS AND METHODS OF USE
#795Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
#796MG53 COMPOSITIONS AND METHODS OF USE
#797Mouse model for depression, schizophrenia and alzheimer's disease and the use thereof
#798RNA sequence-specific mediators of RNA interference
#799BETA-SECRETASE ENZYME COMPOSITIONS AND METHODS
#800Transgenic Aves Producing Human Polyclonal Antibodies
#801Genetically modified non-human mammals and cells
#802Screening methods for compounds useful for treating pancreatic dysfunction
#803Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
#804THEM5-MODIFIED MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE
#805RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
#806Method for selective control of helper T cell function
#807Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof
#808Humanized FcgR mice
#809Methods for treating osteoporosis with anti-IL-20 receptor antibodies
#810Novel gene disruptions, compositions and methods relating thereto
#811Treatment with a pharmaceutical composition comprising MANF2 necleic acid
#812COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS
#813RNA sequence-specific mediators of RNA interference
#814Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
#815RNA sequence-specific mediators of RNA interference
#816RNA sequence-specific mediators of RNA interference
#817INHIBITING OBESITY PROGRESSION BY INHIBITING ADIPOCYTE DIFFERENTIATION WITH A PRE-ADIPOCYTE AUTOPHAGY INHIBITOR
#818TRANSGENIC ANIMALS AND USES THEREOF
#819TIKI1 AND TIKI2, WNT INHIBITORS
#820Potential Prognostic Markers and Therapeutic Targets for Neurological Disorders
#821Vascular endothelial growth factor 2
#822Histone deacetylases, and uses related thereto
#823Evaluation/screening method for diseases associated with D-amino acid utilizing DAO1-/-mouse
#824Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
#825Genetically modified mice and engraftment
#826NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
#827METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ARTIODACTYLS
#828ARTERY- AND VEIN-SPECIFIC PROTEINS AND USES THEREFOR
#829Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
#830Novel Gene Disruptions, Compositions and Methods Relating Thereto
#831Peptides that target dorsal root ganglion neurons
#832CISD2-Knockout Mice and Uses Thereof
#833NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
#834MODULATION OF GM98 (MRF) IN REMYELINATION
#835Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof
#836Gene disruptions, compositions and methods relating thereto
#837NOVEL GPR101 TRANSGENIC MICE AND METHODS OF USE THEREOF
#838Compositions and methods for decreasing type III deiodinase activity to modulate adiposity and blood glucose levels
#839TRANSGENIC ANIMALS EXPRESSING ANTIBODIES SPECIFIC FOR GENES OF INTEREST AND USES THEREOF
#840Humanized FcγR mice
#841Heparanase deficient non-human mammals
#842Method for modifying chromosomes
#843Compositions and methods for the treatment of cancer
#844Compositions and Methods for Increasing Bone Mineralization
#845Mice that make heavy chain antibodies
#846Genetically Modified Rat Models for Pharmacokinetics
#847TRANSGENIC MICE HAVING A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PHENOTYPE, EXPERIMENTAL USES AND APPLICATIONS
#848Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#849DEFICIENCY IN THE HISTONE DEMETHYLASE JHDM2A RESULTS IN IMPAIRED ENERGY EXPENDITURE AND OBESITY
#850Role of PI3K p110 delta Signaling in Retroviral Infection and Replication
#851RNA interference mediating small RNA molecules
#852ANIMALS WITH REDUCED BODY FAT AND INCREASED BONE DENSITY
#853knockout mice and elucidation of association of with early onset degenerative joint disease and role as a tumor suppressor
#854Novel Gene Disruptions, Compostitions and Methods Relating Thereto
#855Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases
#856Mouse λ light chain locus
#857COMPOSITIONS AND METHODS FOR MEDIATING CELL CYCLE PROGRESSION
#858USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
#859Transgenic mouse comprising a disrupted Fibulin-4 gene as a model for cardiovascular disease
#860Transgenic rodents having NGF beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins
#861Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#862SYSTEMS AND METHODS FOR IDENTIFICATION OF CILIOPATHY THERAPEUTICS
#863RNA interference mediating small RNA molecules
#864Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates
#865Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
#866Iduronidase knock-out mouse
#867RNA interference mediating small RNA molecules
#868Methods of inhibiting tumor cell proliferation
#869RNA interference mediating small RNA molecules
#870Nucleic acid molecules and polypeptides for immune modulation
#871METHOD OF PRODUCING NON-HUMAN MAMMALS
#872Chd5 is a novel tumor suppressor gene
#873TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION
#874METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES
#875RNA interference mediating small RNA molecules
#876TAJ in Neuronal Function
#877HEAT SHOCK PROTEIN DEFICIENCIES AS MODEL SYSTEMS FOR BRAIN PATHOLOGY AND CANCER
#878CANDIDATE GENES AND BLOOD BIOMARKERS FOR BIPOLAR MOOD DISORDER, ALCOHOLISM AND STRESS DISORDER
#879Substances and compositions for enhancing DNA repair and methods of use
#880Promoter-regulated differentiation-dependent self-deleting cassette
#881miRNA-regulated differentiation-dependent self-deleting cassette
#882Multi-transgenic pigs for diabetes treatment
#883Genetically Modified Rat Models for Drug Metabolism
#884Truncated activin type II receptor and methods of use
#885COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY
#886Transgenic Animal Model of Cancer and Methods of Use
#887Diagnosis and treatment of autism using CD38
#888RNA interference mediating small RNA molecules
#889Functional Disruption Of Avian Immunoglobulin Genes
#890Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease
#891MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE
#892METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION
#893Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8
#894RNA interference mediating small RNA molecules
#895Methods for inhibiting angiogenesis using EGFL8 antagonists
#896RNA interference mediating small RNA molecules
#897PRODUCTS AND THEIR USE FOR THE DIAGNOSIS, PREVENTION AND/OR CARE OF HUMAN AND/OR ANIMAL PATHOLOGIES CHARACTERISED BY THE ANOMALOUS DEPOSITION OF B-AMYLOID AND/OR AMYLOID-LIKE SUBSTANCE IN HUMAN AND/OR ANIMAL ORGANS AND TISSUES, AND SCREENING METHOD FOR DETERMINING THE RISK OF SUCH PATHOLOGIES
#898Animal Model and Use of 17Beta-Hydroxysteroid Dehydrogenase Type 7 in the Diagnosis of Anencephaly
#899Methods and compositions for mitochondrial replacement therapy
#900REGULATION OF CARDIAC CONTRACTILITY AND HEART FAILURE PROPENSITY